Peer review reports
From: Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy
Original Submission |
26 Nov 2020 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
29 Dec 2020 |
Reviewed |
Reviewer Report
|
6 Jan 2021 |
Reviewed |
Reviewer Report
|
28 Jan 2021 |
Author responded |
Author comments - Meng-Ru Shen
|
Resubmission - Version 5 |
28 Jan 2021 |
Submitted |
Manuscript version 5
|
2 Feb 2021 |
Author responded |
Author comments - Meng-Ru Shen
|
Resubmission - Version 6 |
2 Feb 2021 |
Submitted |
Manuscript version 6
|
9 Feb 2021 |
Reviewed |
Reviewer Report
|
15 Feb 2021 |
Reviewed |
Reviewer Report
|
Resubmission - Version 7 |
|
Submitted |
Manuscript version 7
|
Publishing |
17 Feb 2021 |
Editorially accepted |
|
2 Mar 2021 |
Article published |
10.1186/s12885-021-07926-1
|
Learn about peer review